Drug Shortage Report for TARO-RISPERIDONE
Report ID | 129539 |
Drug Identification Number | 02328313 |
Brand name | RAN-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-11-10 |
Estimated end date | 2021-02-19 |
Actual end date | 2021-02-09 |
Shortage status | Resolved |
Updated date | 2021-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-03 | English | Compare |
v2 | 2020-12-03 | French | Compare |
v3 | 2021-01-31 | English | Compare |
v4 | 2021-01-31 | French | Compare |
v5 | 2021-02-14 | English | Compare |
v6 | 2021-02-14 | French | Compare |
Showing 1 to 6 of 6